By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
AdkhabarAdkhabarAdkhabar
Notification Show More
Font ResizerAa
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Reading: DSS, Inc. Reports Going Concern Audit Opinion in 2025 10-K Filing
Share
Font ResizerAa
AdkhabarAdkhabar
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Search
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Follow US
Adkhabar > Blog > Technology > DSS, Inc. Reports Going Concern Audit Opinion in 2025 10-K Filing
DSS, Inc. Reports Going Concern Audit Opinion in 2025 10-K Filing
Technology

DSS, Inc. Reports Going Concern Audit Opinion in 2025 10-K Filing

GlobeNews Wire
Last updated: 09/05/2026 8:38 AM
GlobeNews Wire
Published: 09/05/2026
Share
SHARE

May 08, 2026 17:00 ET  | Source: DSS, Inc.

ROCHESTER, N.Y., May 08, 2026 (GLOBE NEWSWIRE) — DSS, Inc. (NYSE American: DSS) announced that its annual report (10-K) for the fiscal year ending December 31, 2025, filed on March 31, 2026, includes an audit opinion from HTL International LLC. that contains a “going concern” qualification. This announcement is made pursuant to NYSE American LLC Company Guide Section 610(b), which requires public announcement of the receipt of an audit opinion containing a going concern paragraph and does not represent any change or amendment to the Company’s financial statements for the year ended December 31, 2025.

Again, this announcement does not represent any change or amendment to the Company’s financial statements or to its Annual Report on Form 10-K for the year ended December 31, 2025.

About DSS, Inc.

DSS, Inc. (NYSE American: DSS) is a multinational company operating across multiple business lines including product packaging, biotechnology, commercial lending, and securities and investment management. The Company operates a business model based on developing high-growth subsidiaries and unlocking value through strategic IPOs and public listings. For more information, visit www.dssworld.com.

Forward-Looking Statements

The foregoing material may contain “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, each as amended. Forward-looking statements include all statements that do not relate solely to historical or current facts, including without limitation statements regarding the Company’s product development and business prospects, and can be identified by the use of words such as “may,” “will,” “expect,” “project,” “estimate,” “anticipate,” “plan,” “believe,” “potential,” “should,” “continue” or the negative versions of those words or other comparable words. Forward-looking statements are not guarantees of future actions or performance. These forward-looking statements are based on information currently available to the Company and its current plans or expectations and are subject to a number of risks and uncertainties that could significantly affect current plans. Should one or more of these risks or uncertainties materialize, or the underlying assumptions prove incorrect, actual results may differ significantly from those anticipated, believed, estimated, expected, intended, or planned. Although the Company believes that the expectations reflected in the forward-looking statements are reasonable, the Company cannot guarantee future results, performance, or achievements. Except as required by applicable law, including the securities laws of the United States, the Company does not intend to update any of the forward-looking statements to conform these statements to actual results.

For investor and media inquiries or additional information, please contact: Investor Contact: DSS, Inc. Investor Relations ir@dssworld.com +1 (585) 565-2422.

Valneva Announces Lifting of European Medicines Agencys Temporary Restriction on Use of Chikungunya Vaccine IXCHIQ in Elderly
Secret Ingredient’s 2025: Redefining Hospitality through Story, Space and Strategy
SafeTree Reinforces Leadership in Surrogate Insurance as Demand Rises 50% in 2025
INVO Fertility Receives Notice of Allowance for Modified INVOcell Device Patent
KuCoin Futures Unveils $10 Million Initiative to Empower Affiliates and Ecosystem Partners, Shaping Million-Dollar Star Partners
TAGGED:10-k2025auditconcerndssfilinggoinginc.newsNYSE:DSSopinionreportsUS25614T2006
Share This Article
Facebook Email Print
- Advertisement -

Follow US

Find US on Social Medias
FacebookLike
XFollow
YoutubeSubscribe

Weekly Newsletter

Subscribe to our newsletter to get our newest articles instantly!
Popular News
Rocket Doctor Announces Granting of RSUs and Options
Technology

Rocket Doctor Announces Granting of RSUs and Options

GlobeNews Wire
GlobeNews Wire
13/01/2026
Xinhua Silk Road: Chinese county stages white porcelain exhibition in Geneva
Hydreight Announces $10 Million Bought Deal Private Placement
CJ 4DPLEX’S MULTISENSORY 4DX PREMIUM FORMAT DELIVERS RECORD-BREAKING GROWTH IN INDIA IN 2025
Louis Limited Sets New Standard for Trading Psychology With Dynamic Emotion Tracking Features
- Advertisement -
- Advertisement -
- Advertisement -

Categories

  • Automobile
  • Entertainment
  • E-Sports
  • Food
  • Health
  • Technology
  • LifeStyle
  • Travel

About Us

Through our news networks, we raise millions of users' awareness. We are among the world's most reputable news networks.
Quick Link
Top Categories
  • Entertainment

Subscribe US

Subscribe to our newsletter to get our newest articles instantly!

AdkhabarAdkhabar
Copyright © 2021 - 2025 AdKhabar. All Rights Reserved. POWERED BY Life Care News.
Join Us!
Subscribe to our newsletter and never miss our latest news, podcasts etc..
Zero spam, Unsubscribe at any time.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?